The Hearing-Cognition Link:
What Untreated Hearing Loss
Does to the Aging Brain

Harold was seventy-eight when his daughter first noticed something was wrong — not with his ears, but with his mind. He was repeating himself at dinner, misplacing objects, struggling to follow the plot of films he would once have dissected in detail. The family began quietly dreading the word no one wanted to say. What they had not connected — what almost no one had told them — was that Harold had spent the previous six years refusing to wear the hearing aids his audiologist had prescribed. They were uncomfortable, he said. They made everything too loud. He couldn't be bothered.

Harold's story is not unusual. It is, in the emerging view of neuroscience, a story about the brain far more than it is about the ears.

The relationship between hearing loss and dementia is one of the most consequential and least-understood connections in aging medicine. Research over the past decade has moved it from a curious correlation to the center of serious scientific and public health debate. The 2020 Lancet Commission on Dementia Prevention, Intervention, and Care — a landmark report that reviewed virtually every known modifiable risk factor for dementia — concluded that hearing loss in midlife is the single largest potentially modifiable risk factor for dementia, estimated to account for around 8 percent of all cases worldwide. That figure was revised upward in the Commission's 2024 update.

Read that again carefully: not one of the risk factors. The largest. Above smoking. Above physical inactivity. Above high blood pressure. Above diabetes. Above obesity.

And yet the majority of older adults with hearing loss do not treat it.

The Number That Should Alarm Everyone

In a landmark longitudinal study from Johns Hopkins, researchers tracked 639 adults over nearly twelve years. Those with mild hearing loss had roughly double the risk of developing dementia compared to those with normal hearing. Moderate loss tripled the risk. Severe hearing loss — the kind most often left untreated — was associated with five times the dementia risk.

These are not small effects. To put it in perspective: the APOE4 gene variant, the most significant known genetic risk factor for Alzheimer's disease, approximately doubles to triples a person's lifetime risk. Severe untreated hearing loss produces a comparable shift in risk — and, unlike your genes, it is something you can do something about.

A 2024 meta-analysis combining data from fifty cohort studies encompassing more than 1.5 million participants concluded that adult-onset hearing loss significantly increases the risk of cognitive decline, dementia, mild cognitive impairment, and Alzheimer's disease. This is not a marginal finding from a single lab. It is a convergent conclusion from decades of independent research across continents.

Three Ways Hearing Loss Attacks the Brain

Understanding why hearing loss raises dementia risk requires understanding something that is not obvious: hearing is not a passive act. You do not hear with your ears. You hear with your brain. The ear is merely an antenna — it collects and converts vibrations into electrical signals. Everything that makes sound meaningful — parsing words, filtering noise, tracking a conversation across a dinner table, recognizing your grandchild's voice — happens in the brain. And when the antenna degrades, the brain pays the price in three distinct ways.

What makes this especially alarming is that these three pathways do not operate independently. They reinforce each other. A person who strains to hear at family dinners begins to avoid them; a brain deprived of social stimulation and meaningful conversation shrinks more quickly; a shrinking brain becomes less able to cope with the degraded auditory signal; the listening effort increases further. It is, in the most literal sense, a downward spiral.

What MRI Scans Show

For decades, the evidence linking hearing loss and dementia was epidemiological — associations observed in large populations over time. Compelling, but not mechanistic. In the past decade, neuroimaging has begun to tell a starker story.

A study using the Johns Hopkins Baltimore Longitudinal Study of Aging tracked brain volume changes in adults with and without hearing impairment over an average of 6.4 years. Those with hearing impairment showed significantly accelerated brain atrophy, concentrated in the right temporal lobe — the region most responsible for language processing and auditory association. The magnitude of this difference was comparable to the volume loss observed in adults transitioning from normal cognition to mild cognitive impairment.

A larger study drawing on over 165,000 participants in the UK Biobank, along with the Chinese Alzheimer's Biomarker and Lifestyle study and the Alzheimer's Disease Neuroimaging Initiative, found that poor hearing performance was associated with reduced gray matter volume in the temporal cortex, hippocampus, inferior parietal lobe, and precuneus — areas that closely overlap the regions first attacked by Alzheimer's disease. The same study found that hearing impairment was associated with elevated tau protein in cerebrospinal fluid, a hallmark biomarker of Alzheimer's pathology.

This is the part that is important to sit with: the brain changes associated with untreated hearing loss are not abstract statistical associations. They are measurable, structural, visible on a scan. The question of whether they are reversible — and to what degree treating hearing loss can halt or slow them — is one of the most urgent open questions in aging research.

The ACHIEVE Trial: What We Now Know

The most rigorous evidence to date on whether treating hearing loss can slow cognitive decline comes from the ACHIEVE study — the Aging and Cognitive Health Evaluation in Elders — a multi-center randomized controlled trial led by Dr. Frank Lin at Johns Hopkins and published in The Lancet in July 2023.

ACHIEVE enrolled 977 adults aged 70 to 84 with untreated hearing loss, randomly assigning them to either a comprehensive hearing intervention — audiologist-fitted hearing aids, counseling, and communication strategy training — or a health education control. Participants were followed for three years with repeated cognitive assessments.

The headline result was deliberately nuanced: in the total study population, the hearing intervention did not produce a statistically significant reduction in cognitive decline at three years. For many people, this was reported as "hearing aids don't prevent dementia" — a reading the researchers themselves pushed back on.

The real finding was more precise, and more important. When the researchers examined a pre-specified subgroup — the 238 participants who came from an existing cardiovascular study and had more risk factors for cognitive decline — the hearing intervention reduced cognitive change by 48 percent over three years. Nearly half.

The reason the benefit appeared in this group and not the healthy volunteers is almost certainly statistical: the volunteers were so cognitively healthy that neither group showed meaningful decline within three years. The effect, in other words, was not absent — it was undetectable in a population declining too slowly to measure. ACHIEVE investigators are continuing to follow all participants beyond three years precisely to capture longer-term effects.

The Stigma That Is Costing People Their Minds

Roughly 75 percent of people who would benefit from hearing aids do not use them. The reasons are well-documented: cost, inconvenience, social stigma, denial, and the genuine frustration of an initial adjustment period during which a hearing aid can feel worse than nothing at all.

That last point deserves special attention, because it may be the most fixable of the barriers. Hearing aids do not restore hearing the way glasses restore vision. The brain has spent years, perhaps decades, adapting to degraded auditory input. When a device suddenly delivers cleaner, fuller sound, the brain needs time — often weeks or months — to recalibrate. Sounds can seem too sharp, too present, too unfamiliar. Many people abandon their hearing aids during this adjustment period, concluding that the devices do not work.

One of the most common and least-discussed complaints is that hearing aids make everything sound tinny — thin, harsh, almost metallic. This is not a flaw in the device. It is the brain's confused response to high-frequency sounds it had long stopped hearing.

Age-related hearing loss almost always affects high frequencies first: the consonants that give speech its crispness, the upper harmonics that give voices their warmth and distinction, the ambient texture that makes a room sound full. The brain adapts to their absence over years. When a hearing aid restores them, the brain — having effectively forgotten what they sound like — registers the unfamiliar as wrong. What is actually correct sounds artificial. What sounds natural is, in fact, impoverished.

The person's own voice is often the most jarring of all. It can seem too loud, too resonant, almost echoing inside their own head. This is a distinct phenomenon called the occlusion effect, caused by the hearing aid blocking the ear canal and trapping low-frequency vibrations. Modern open-fit and receiver-in-canal designs were developed specifically to reduce this — leaving the canal partially open restores a more natural quality to the wearer's own voice and eliminates much of the hollow character associated with older devices.

A competent audiologist will program around the tinniness problem from the start. Standard practice is not to set a hearing aid to full prescription on day one. Gain is kept deliberately conservative initially — enough to provide meaningful benefit, but not enough to overwhelm a brain adjusting to sounds it had effectively stopped processing. Settings are increased progressively over weeks or months as acclimatization proceeds. If someone was handed a device at full gain and told to get on with it, what they experienced was a fitting problem, not an inherent limitation of hearing aids.

For most people who persist through the first four to eight weeks, the tinniness fades as the brain recalibrates its expectations. Many then report that removing their aids makes unaided hearing sound muffled by comparison — the richer baseline has become the reference point. The transition is uncomfortable precisely because it is working.

This is the auditory equivalent of putting on corrective lenses for the first time and, because everything looks curved and strange at the edges, concluding that glasses are useless. The strangeness is not evidence of failure. It is evidence of correction.

The adjustment is real. It is also temporary. Audiologists who specialize in older adults typically recommend a structured trial period with graduated wear time and regular follow-up appointments — a model that significantly improves long-term adoption and satisfaction. Anyone who gave up because of tinniness or harshness in the first weeks should raise it explicitly at a follow-up visit. It is among the most solvable problems in audiology.

As for cost: the FDA's 2022 ruling permitting over-the-counter hearing aids for mild to moderate hearing loss has substantially reduced the price barrier for many adults. OTC devices now start well under $500, compared to the $1,000–$5,000 range historically required for prescription aids. These devices are not appropriate for all types or degrees of hearing loss, and a qualified audiologist remains invaluable for fitting and follow-up — but the financial wall that once excluded millions has been substantially lowered.

The Isolation Mechanism: Why Your Ears Affect Your Social Brain

There is a third story embedded in all of this that tends to receive less attention than the neuroscience, but which may be equally important. Hearing loss does not just change how a person processes sound. It changes who they are willing to be around.

Straining to hear is exhausting in a way that people with normal hearing rarely appreciate. Following a conversation in a noisy restaurant requires an older adult with hearing loss to devote extraordinary cognitive effort to a task that should be automatic. The result, over time, is avoidance. The person stops going to the restaurant. They stop attending family gatherings they can't follow. They stop calling friends they can't hear on the phone. They withdraw.

And social withdrawal is, independently of everything else discussed in this article, one of the most consistently identified risk factors for cognitive decline and dementia. The brain is a social organ. It was shaped by millions of years of evolution to operate in complex social environments — tracking intentions, parsing language, reading faces and voices simultaneously. When that stimulation is removed, the consequences are neurological, not merely emotional.

A secondary analysis of the ACHIEVE trial, published in JAMA Internal Medicine in 2025, found that the hearing intervention not only affected cognitive outcomes — it significantly improved social functioning and reduced loneliness. Even when cognitive effects were uncertain, the social effects were consistent and clear.

Dementia Is Not Inevitable — And Neither Is Isolation

It is important to be precise about what the science does and does not say. Treating hearing loss does not guarantee that a person will not develop dementia. Dementia has many causes — genetic, vascular, metabolic, environmental — and hearing intervention is not a cure for any of them. The science does not support the conclusion that hearing aids prevent Alzheimer's disease.

What the science does support — with increasing confidence, across multiple independent lines of evidence — is this: untreated hearing loss adds a meaningful, measurable burden to an aging brain that is already managing many challenges. It makes the brain work harder for less result. It erodes the brain structures most vulnerable to neurodegeneration. It drives a person away from the social engagement their brain needs most. And it does this slowly, invisibly, over years — in a way that is easy to attribute to "just getting older."

The converse is equally supported: treating hearing loss removes or reduces that burden. It redirects cognitive resources from the struggle to hear back toward the work of thinking, remembering, and engaging with the world. It may not rewind the clock, but it may significantly slow it.

A Conversation Worth Having

Harold's daughter eventually sat with him and explained what she had learned. Not as an argument about hearing aids, but as a conversation about his brain — the thing he actually cared about protecting. She told him that the audiologists weren't pushing hearing aids to make him feel old. They were trying to protect him from what he feared most.

She told him about the research. About the brain scans showing atrophy. About the Johns Hopkins study. About the man in the trial who, after three years with hearing aids, had measurably slower cognitive decline than the man who had declined them. She told him it would be uncomfortable at first, and that this was expected, and that they would work through the adjustment together.

He agreed to try. Not because the devices had become more comfortable overnight. Because someone had finally connected the dots for him between the drawer where the hearing aids sat untouched and the future he was most afraid of.

That conversation — the one between a patient who fears dementia and a family member or clinician who understands the hearing-cognition link — may ultimately be as important as any device, any trial, any treatment protocol. The science has done its work. What is needed now is for that science to travel the much shorter and harder distance from the research literature into the rooms where it matters.

The Auditory Review publishes science and medicine writing for clinicians, researchers, and informed general readers. This article is intended for educational purposes and does not constitute medical advice. Readers with concerns about hearing loss or cognitive health should consult a qualified audiologist or physician.